Patent directory · USPTO A61K / A61P
Patents matching “The United States of America as represented by the Secretary of the Department of”
389 pharma patents match "The United States of America as represented by the Secretary of the Department of" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 389 pharmaceutical patents matching "The United States of America as represented by the Secretary of the Department of" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 8163545
Vaccine against pandemic strains of influenza viruses
granted -
US 8158603
Fragments of secreted frizzled related protein
granted -
US 8148323
Method of treating or inhibiting inflammation by multi-domain amphipathic helical peptides
granted -
US 8143252
Tetrahalogenated compounds useful as inhibitors of angiogenesis
granted -
US 8129351
Immunostimulatory nucleic acid molecules
granted -
US 8119642
Structurally rigid dopamine D3 receptor selective ligands and process for making them
granted -
US 8114406
Peptides and their utility in modulation of behavior of cells expressing α3β1 integrins
granted -
US 8106006
Modified defensins and their use
granted -
US 8105598
Human monoclonal antibodies that specifically bind IGF-II
granted -
US 8105609
Flavivirus immunogens comprising extracellular viral particles composed of the premembrane (prM) and envelope (E) antigens
granted -
US 8106026
Development of a preventive vaccine for filovirus infection in primates
granted -
US 8092809
Pseudomonas exotoxin A-like chimeric immunogens
granted -
US 8084250
Defensin-antigen fusion proteins
granted -
US 8084415
Uteroglobin in the treatment of IGA mediated nephropathy
granted -
US 8080554
Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
granted -
US 8075921
Rapamycin-resistant T cells and therapeutic uses thereof
granted -
US 8071323
Human monoclonal antibodies that bind human insulin like growth factors and their use
granted -
US 8067563
Tumor suppressor gene, p471NG3
granted -
US 8058249
Immunostimulatory nucleic acid molecules
granted -
US 8048432
Polysaccharide-protein conjugate vaccines
granted -
US 8044057
Methods for suppressing an immune response or treating a proliferative disorder
granted -
US 8044185
Conformationally stabilized HIV envelope immunogens and triggering HIV-I envelope to reveal cryptic V3-loop epitopes
granted -
US 8043622
Method of treating inflammatory lung disease with suppressors of CpG oligonucleotides
granted -
US 8038997
Anti-marinobufagenin antibodies and methods for their use
granted